Project Number ARUK-PG2017B-19 Agency/Funding Organization Alzheimer's Research UK Funding Year 2018 View Full Project Details for New therapeutics in Alzheimer’s disease: MEG biomarker platform development Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 8. Novel Analyses, Methodologies and Techniques for Biomarker Discovery and Validation Researcher and Organization Principal Investigator James Rowe Principal Investigator First Name Rowe Principal Investigator Last Name James Awardee Organization UNIVERSITY OF CAMBRIDGE Contact PI Country United Kingdom Project Detail FY Overall Cost $100,000 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
